Related Articles

News
STAT+: Pharmalittle: Abortion pills will be at center of legal battles; Gilead reaches $33 million settlement over patient assistance programs
June 27, 2022
San Francisco Biotechnology Network News
News
Comments Off on STAT+: Pharmalittle: Abortion pills will be at center of legal battles; Gilead reaches $33 million settlement over patient assistance programs
Abortion pills, already used in more than half of abortions in the U.S., are becoming even more sought-after in the aftermath of Roe v. Wade being overturned. […]

News
STAT+: Gilead, Arcus anti-TIGIT drug reduces risk of lung cancer progression in mid-stage study
December 19, 2022
San Francisco Biotechnology Network News
News
Comments Off on STAT+: Gilead, Arcus anti-TIGIT drug reduces risk of lung cancer progression in mid-stage study
The Phase 2 study results from Gilead and Arcus could augur a comeback of sorts for the entire class of TIGIT-targeted antibody treatments. […]

News
STAT+: Pharmalittle: Judge rules Walgreens helped fuel San Francisco opioid crisis; U.S. plan to bottle monkeypox vaccine could take months
August 11, 2022
San Francisco Biotechnology Network News
News
Comments Off on STAT+: Pharmalittle: Judge rules Walgreens helped fuel San Francisco opioid crisis; U.S. plan to bottle monkeypox vaccine could take months
A U.S. federal judge ruled that Walgreens helped fuel the opioid epidemic in San Francisco by shipping thousands of “suspicious orders” of prescription drugs to its pharmacies. […]